Mumbai based pharma company Cipla Limited has posted a steep drop in net profit for the period Q4 (ending Mar 11) of the current fiscal (FY10-11). During the said quarter, net profit declines 22.33% to Rs 214.0 crores in comparison to Rs 275.5 crores of Q4 (ending Mar 10) of previous year (FY09-10). Cipla Limited is a prominent Indian pharmaceutical company, best-known outside its home country for manufacturing low-cost anti-AIDS drugs for HIV-positive patients in developing countries. The company was founded by Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories (CIPLA) in 1935.
The company has informed the share market (BSE/NSE) that the total income rose 19% to Rs 1689.55 crore in Q4 (ending Mar 2011) of the current fiscal (FY10-11) when compared with the same quarter Q4 (ending Mar 2010) of previous year (FY09-10). Total income was Rs 1419.77 crores in last year’s quarter Q4.
Share’s Data :-
BSE Code : 500087
Mkt. Cap : Rs 24,359.99 Crores
Cipla Ltd. share’s CMP is Rs 303.40 on 5th May 2011.
Stay tuned to BelltheBull Blog for more news on Cipla Limited !Google+